Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-genentech.jpg" NAME"Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire" ALT"Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire"February 7, 2017By Mark Terry, BioSpace... Source: BioSpace

Continue ReadingGenentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire

Eli Lilly Seeks "Voluntary Exits" From 200 Researchers

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-eli-lilly.jpg" NAME"Eli Lilly Seeks Voluntary Exits From 200 Researchers" ALT"Eli Lilly Seeks Voluntary Exits From 200 Researchers"February 6, 2017By Alex Keown, BioSpace.com Breaking News StaffINDIANAPOLIS... Source: BioSpace

Continue ReadingEli Lilly Seeks "Voluntary Exits" From 200 Researchers